Harvard Bioscience Inc banner

Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 0.6137 USD 2.13% Market Closed
Market Cap: $27.4m

Wall Street
Price Targets

HBIO Price Targets Summary
Harvard Bioscience Inc

Wall Street analysts forecast HBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HBIO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

Lowest
Price Target
2.02 USD
229% Upside
Average
Price Target
2.04 USD
232% Upside
Highest
Price Target
2.1 USD
242% Upside
Harvard Bioscience Inc Competitors:
Price Targets
TES
Tesmec SpA
-8% Downside
DHR
Danaher Corp
30% Upside
0IF
LogicBio Therapeutics Inc
68% Upside

Revenue
Forecast

-1% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-1% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Harvard Bioscience Inc's revenue is -1%. The projected CAGR for the next 3 years is 1%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-67%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-67%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HBIO's stock price target?
Price Target
2.04 USD

According to Wall Street analysts, the average 1-year price target for HBIO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

What is Harvard Bioscience Inc's Revenue forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Harvard Bioscience Inc's revenue is -1%. The projected CAGR for the next 3 years is 1%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett